ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study to Determine the Prevalence of Homologous Recombination Deficiency Among Women With Newly Diagnosed, High-grade, Serous or Endometrioid Ovarian, Primary Peritoneal, and/or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC
- Status
- UNKNOWN
- Phase
- PHASE2
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
- Status
- WITHDRAWN
- Phase
- N/A
A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib
- Status
- COMPLETED
- Phase
- PHASE3
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BrUOG 390: Neoadjuvant Treatment With Talazoparib
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
- Status
- COMPLETED
- Phase
- N/A
Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients
- Status
- COMPLETED
- Phase
- NA